Surface displayed expression of a neutralizing epitope of spike protein from a Korean strain of porcine epidemic diarrhea virus

Biotechnology and Bioprocess Engineering

Volumn 12, Issue 6, 2007, Pages 690-695

  Park, Seung Moon ^a   Mo, Ae Young ^a   Lim, Jung Gu ^a   Chung, Hea Jong ^a   Kim, Tae Geum ^a   Kim, Kang Ju ^b   Cho, Dong Ha ^c   Yang, Moon Sik ^a   Kim, Dae Hyuk ^a  

^a Chonbuk National University   (South Korea)

^b Wonkwang University   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

Porcine epidemic diarrhea virus; Saccharomyces cerevisiae; Surface display

Indexed keywords

AGGLUTININ; ALPHA 1,3 GLUCANASE; ALPHA AGGLUTININ; AMYLASE; AMYLASE 1A; BETA MANNOSIDASE; EPITOPE; FLUORESCEIN ISOTHIOCYANATE; GLUCAN GLUCOSIDASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN G; POLYCLONAL ANTIBODY; SIGNAL PEPTIDE; SPIKE PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL FOOD; ARTICLE; BACTERIAL STRAIN; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CELL WALL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONAVIRUS; GENE EXPRESSION; GENE FUSION; KOREA; NONHUMAN; PORCINE EPIDEMIC DIARRHEA VIRUS; PROMOTER REGION; RECOMBINANT PLASMID; SACCHAROMYCES CEREVISIAE; WESTERN BLOTTING;

ANIMALIA; CAPRA HIRCUS; PORCINE EPIDEMIC DIARRHEA VIRUS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCETALES;

EID: 38349078119     PISSN: 12268372     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931087     Document Type: Article

References (41)

1. Egberink, H. F., J. Ederveen, P. Callebaut, and M. C. Horzinek (1988) Characterization of the structural proteins of porcine epizootic diarrhea virus, strain CV777. Am. J. Vet. Res. 49: 1320-1324.
2. Pensaert, M. B. and P. de Bouck (1978) A new coronavirus-like particle associated with diarrhea in swine. Arch. Virol. 58: 243-247.
3. Wood, E. N. (1977) An apparently new syndrome of porcine epidemic diarrhea. Vet. Rec. 100: 243-244.
4. Chae, C., O. Kim, C. Choi, K. Min, W. S. Cho, J. Kim, and J. H. Tai (2000) Prevalence of porcine epidemic diarrhea virus and transmissible gastroenteritis viras infection in Korean pigs. Vet. Rec. 147:606-608
5. Jimenez, G., J. M. Castro, M. del Pozzo, I. Correa, J. de la Torre, and L. Enjuanes (1986) Identification of a coronavirus inducing porcine gastroenteritis in Spain. Proc. Int. Pig Vet. Soc. Congr. 9: 186.
6. Pensaert, M. B. (1999) Procine epidemic diarrhea, pp. 179-185. In: B. E. Straw, S. D'Allaire, W. L. Mengeling, and D. I. Taylor (eds.). Diseases of Swine. Iowa University Press, Iowa, USA.
7. Ducatelle, R., W. Coussement, M. Pensaert, P. de Bouck, and J. Hoorens (1981) In vivo morphogenesis of a new porcine enteric coronavirus, CV777. Arch. Virol. 68: 35-44.
8. Knuchel, M., M. Ackermann, H. K. Muller, and U. Kihm (1992) Ah ELISA for detection of antibodies against porcine epidemic diarrhea virus (PEDV) based on the specific solubility of the viral surface glycoprotein. Vet. Microbiol. 32:117-134.
9. Duarte, M. and H. Laude (1994) Sequence of the spike protein of the porcine epidemic diarrhoea viras. J. Gen. Virol. 75:1195-1200.
10. Chang, S. H., J. L. Bae, T. J. Kang, J. Kim, G. H. Chung, C. W. Lim, H. Laude, M. S. Yang, and Y. S. Jang (2002) Identification of the epitope region capable of inducing neutralizing antibodies against the porcine epidemic diarrhea viras. Mol. Cells 14: 295-299.
11. Kang, T. J., J. E. Seo, D. H. Kim, T. G. Kim, Y. S. Jang, and M. S. Yang (2005) Cloning and sequence analysis of the Korean strain of spike gene of porcine epidemic diarrhea virus and expression of its neutralizing epitope in plants. Protein Expr. Purif. 41: 378-383.
12. Bae, J. L., J. G. Lee, T. J. Kang, H. S. Jang, Y. S. Jang, and M. S. Yang (2003) Induction of antigen-specific systemic and mucosal immune responses by feeding animals transgenic plants expressing the antigen. Vaccine 21: 4052-4058.
13. Service, R. F. (1994) Triggering the first line of defense. Science 265: 1522-1524.
14. Walker, R. I. (1994) New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 12: 387-400.
15. McFarland, L. V. and P. Bernasconi (1993) Saccharomyces boulardii: a review of an innovative biotherapeutic agent. Microb. Ecol. Health Dis. 6: 157-171.
16. Corthier, G., F. Lucas, S. Jouvert, and F. Castex (1992) Effect of oral Saccharomyces boulardii treatment on the activity of Clostridium difficile toxins in mouse digestive tract. Toxicon 30: 1583-1589.
17. Berg, R., P. Bernasconi, D. Fowler, and M. Gautreaux (1993) Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardii. J. Infect. Dis. 168: 1314-1318.
18. Schellenberg, D., A. Bonington, C. M. Champion, R. Lancaster, S. Webb, and J. Main (1994) Treatment of Clostridium difficile diarrhoea with brewer's yeast. Lancet 343: 171-172.
19. Fattal-German, M. and B. Bizzini (1992) Assessment of the anti-viral effect of a short-term oral treatment of mice with live Saccharomyces cerevisiae cells. Dev. Biol. Stand. 77: 115-120.
20. Colby, D. W., B. A. Kellogg, C. P. Graff, Y. A. Yeung, J. S. Swers, and K. D. Wittrup (2004) Engineering antibody affinity by yeast surface display. Methods Enzymol. 388: 348-358.
21. Kondo, A. and M. Ueda (2004) Yeast cell-surface display - applications of molecular display. Appl. Microbiol. Biotechnol. 64: 28-40.
22. Schreuder, M. P., C. Deen, W. J. A. Boersma, P. H. Pouwels, and F. M. Klis (1996) Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine. Vaccine 14: 383-388.
23. In, M. J., D. C. Kim, and H. J. Chae (2005) Downstream process for the production of yeast extract using brewer's yeast cells. BiotechnoL Bioprocess Eng. 10: 85-90.
24. Chen, L. J, Y. L. Xu, F. W. Bai, W. A. Anderson, and M. Moo-Young (2005) Observed quasi-steady kinetics of yeast cell growth and ethanol formation under very high gravity fermentation condition. BiotechnoL Bioprocess Eng. 10:115-121.
25. Nagahisa, K., T. Nakajima, K. Yoshikawa, T. Hirasawa, Y. Katakura, C. Furusawa, S. Shioya, and H. Shimizu (2005) DNA microarray analysis on Saccharomyces cerevisiae under high carbon dioxide concentration in fermentation process. Biotechnol. Bioprocess Eng. 10: 451-461.
26. Hwang, S. Y., C. H. Yoo, J. Y. Jeon, S. C. Choi, and E. K. Lee (2005) Quantitative assay of hepatitis B surface antigen by using surface plasmon resonance biosensor. Biotechnol. Bioprocess Eng. 10: 309-314.
27. Sambrook, J., E. F. Fritsch, and T. Maniatis (1989) Molecular Cloning: A Laboratory Manual. 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA.
28. Shon, J. H., E. S. Choi, B. H. Chung, D. J. Youn, J. H. Seo, and S. K. Rhee (1995) Process development of the production of recombinant hirudin in Saccharomyces cerevisiae: from upstream to downstream. Process Biochem. 30: 653-660.
29. Kim, M. J., T. H. Kwon, Y. S. Jang, M. S. Yang, and D. H. Kim (2000) Expression of murine GM-CSF in recombinant Aspergillus niger. J. Microbiol. Biotechnol. 10: 287-292.
30. Park, E. H., Y. M. Shin, Y. Y. Lim, T. H. Kwon, D. H. Kim, and M. S. Yang (2000) Expression of glucose oxidase by using recombinant yeast. J. Biotechnol. 81: 35-44.
31. Park, S. M., A. Y. Mo, Y. S. Jang, J. H. Lee, M. S. Yang, and D. H. Kim (2004) Expression of a functional human tumor necrosis factor-α (hTNF-α) in yeast Saccharomyces cerevisiae. BiotechnoL Bioprocess Eng. 9: 292-296.
32. Shin, Y. M., T. H. Kwon, K. S. Kim, K. S. Chae, D. H. Kim, J. H. Kim, and M. S. Yang (2001) Enhanced iron uptake of Saccharomyces cerevisiae by heterologous expression of a tadpole ferritin gene. Appl. Environ. Microbiol. 67: 1280-1283.
33. Ge, L. and P. Rudolph (1997) Simultaneous introduction of multiple mutations using overlap extension PCR. Biotechniques 22: 28-30.
34. Lim, Y. Y., E. H. Park, J. H. Kim, S. M. Park, H. S. Jang, Y. J. Park, S. W. Yoon, M. S. Yang, and D. H. Kim (2001) Enhanced and targeted expression of fungal phytase in Saccharomyces cerevisiae. J. Microbiol. Biotechnol. 11: 915-921.
35. Mo, A. Y., S. M. Park, Y. S. Kim, M. S. Yang, and D. H. Kim (2005) Expression of fungal phytase on the cell surface of Saccharomyces cerevisiae. Biotechnol. Bioprocess Eng. 10: 576-581.
36. Ito, H., Y. Fukuda, K. Murata, and A. Kimura (1983) Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153: 163-168.
37. Pringle, J. R., R. A. Preston, A. E. Adams, T. Stearns, D. G. Drubin, B. K. Haarer, and E. W. Jones (1989) Fluorescence microscopy methods for yeast. Methods Cell Biol. 31: 357-435.
38. Loeper, J., B. Louérat-Oriou, C. Duport, and D. Pompon (1998) Yeast expressed cytochrome P450 2D6 (CYP2D6) exposed on the external face of plasma membrane is functionally competent. Mol. Pharmacol. 54: 8-13.
39. Murai, T., M. Ueda, M. Yamamura, H. Atomi, Y. Shibasaki, N. Kamasawa, M. Osumi, T. Amachi, and A. Tanaka (1997) Construction of a starch-utilizing yeast by cell surface engineering. Appl. Environ. Microbiol. 63: 1362-1366.
40. Huang, D. and E. V. Shusta (2005) Secretion and surface display of green fluorescent protein using the yeast Saccharomyces cerevisiae. Biotechnol. Prog. 21: 349-357.
41. Shibasaki, S., M. Ueda, T. Iizuka, M. Hirayama, Y. Ikeda, N. Kamasawa, M. Osumi, and A. Tanaka (2001) Quantitative evaluation of the enhanced green fluorescent protein displayed on the cell surface of Saccharomyces cerevisiae by fluorometric and confocal laser scanning microscopic analyses. Appl. Microbiol. Biotechnol. 55: 471-475.